ArticleAcute medicine & surgery
Cost-Effectiveness of Rule-Guided Head Computed Tomography for Pediatric Head Injury: An Economic Modeling Study Using a Nationwide Claims Database.
Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To evaluate the cost-effectiveness of applying the Pediatric Emergency Care Applied Research Network (PECARN) head injury clinical decision rules versus usual care in Japan. Methods: We developed a public payer-perspective decision tree model by comparing PECARN rule-guided and usual-care computed tomography (CT) strategies for children aged 0-15 years with head injuries. The model captured short-term pathways (clinically important traumatic brain injury [ciTBI], CT use, admission or discharge, and surgery) and lifetime radiation-induced intracranial malignancy risk. Transition probabilities for the PECARN rule were obtained from a multicenter Japanese validation study, and usual-care transitions and costs were estimated from the Japan Medical Data Center (JMDC) nationwide claims database (2012-2019). Life-years were assessed over a lifetime. Uncertainty was explored using one-way and probabilistic sensitivity analyses, and scenario analyses assessed parameters, facility type, short-term hospitalization, and baseline CT utilization. Results: In the base-case analysis, the PECARN rule resulted in lower costs (¥11,391 vs. ¥12,148) and slightly higher effectiveness (39.41303 vs. 39.41296 life-years) than usual care. In probabilistic sensitivity analysis, the PECARN rule was cost-effective in 99.98% of simulations at a willingness-to-pay threshold of ¥5,000,000 per life-year. CT rates among children without ciTBI influenced the net monetary benefit most. Scenario analyses showed that the findings varied by facility type and baseline CT utilization. Conclusion: In average hospital-based usual care in Japan, use of the PECARN rule was associated with lower expected healthcare costs without meaningful loss of effectiveness and may support efficient resource use and reduced radiation exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.